Vaccine development against neglected tropical diseases

Area of Science:

• Tropical medicine
• Vaccinology
• Infectious diseases

Background:

• Neglected tropical diseases disproportionately affect impoverished populations, receiving limited research and pharmaceutical attention.
• Chagas disease, schistosomiasis (Schistosoma mansoni), and leishmaniasis are significant health burdens in Brazil.
• Vaccine development is critical for controlling these diseases but faces substantial challenges.

Purpose of the Study:

• To review the current status of vaccine development for Chagas disease, schistosomiasis, and leishmaniasis in Brazil.
• To provide an overview of vaccine candidates and their developmental stages.
• To identify factors influencing the pace of vaccine development for these neglected diseases.

Main Methods:

• A narrative review of the scientific literature was conducted.
• Publications were systematically searched and analyzed to summarize vaccine development progress.
• The review focused on vaccine candidates for American trypanosomiasis, schistosomiasis, and leishmaniasis.

Main Results:

• Vaccine development for American trypanosomiasis (Chagas disease) has not yet reached clinical evaluation.
• Vaccine candidates for schistosomiasis are in advanced clinical trial phases.
• Licensed veterinary vaccines exist for leishmaniasis, with human vaccine candidates in intermediate clinical development.

Conclusions:

• Vaccine development for these three neglected tropical diseases is at different stages, with varying levels of advancement.
• Insufficient funding is a major impediment to accelerating product development for these diseases.
• Continued investment and research are essential to bring effective vaccines to affected populations.